» Articles » PMID: 32765127

Comparison of Silicone- and Porous-Plate Ahmed Glaucoma Valves

Overview
Publisher Dove Medical Press
Date 2020 Aug 9
PMID 32765127
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Our aim was to evaluate and compare the clinical outcomes after implantation of the silicone-plate (model FP7) and porous polyethylene-plate (model M4) Ahmed Glaucoma Valves.

Patients And Methods: This was a prospective, multicenter, comparative series. A total of 52 eyes (52 patients) were treated with either the silicone or porous plate Ahmed Glaucoma Valve implant. Hypertensive phase was defined as intraocular pressure >21 mmHg during the first 3 months postoperatively. Success was defined as 5 mmHg ≤intraocular pressure ≤21 mmHg (with or without additional glaucoma medications), without loss of light perception and without additional glaucoma procedures. Patients were monitored for 1 year after surgery.

Results: The pre-operative intraocular pressure was 29.9 ± 6.6 mmHg and 33.8 ± 10.5 in the silicone-plate and porous-plate groups, respectively (P = 0.118). At 12 months after surgery, the mean intraocular pressure was 13.6 ± 4.7 mmHg in the silicone-plate group and 17.9 ± 10.9 mmHg in the porous-plate group (P = 0.141). The mean number of glaucoma medications at 12 months was 1.64 ± 1.40 mmHg and 1.89 ± 1.54 mmHg in the silicone- and porous-plate groups, respectively (P = 0.605). Hypertensive phase was not significantly different in the two groups (50.0% of the silicone-plate and 57.7% of the porous-plate groups, P = 0.578). At 12 months after surgery, the percent success for the silicone-plate and porous-plate groups was 88.5% and 53.8%, respectively (P = 0.005). Complications were similar in the two groups.

Conclusion: The porous-plate Ahmed Glaucoma Valve showed similar average intraocular pressure reduction compared with the silicone-plate model. At 12 months after surgery, there was a significantly lower success rate in the porous-plate compared with the silicone-plate group.

Citing Articles

Evaluating the Safety and Efficacy of a Novel Glaucoma Drainage Device in High-Risk Adult Glaucoma Patients: A One-Year Pilot Study.

Ahmed F, Normando E, Ahmed S, Virdee S, Al-Nahrawy A J Clin Med. 2024; 13(17).

PMID: 39274211 PMC: 11396561. DOI: 10.3390/jcm13174996.

References
1.
Kim J, Allingham R, Hall J, Klitzman B, Stinnett S, Asrani S . Clinical experience with a novel glaucoma drainage implant. J Glaucoma. 2013; 23(2):e91-7. DOI: 10.1097/IJG.0b013e3182955d73. View

2.
Cvintal V, Moster M, Shyu A, McDermott K, Ekici F, Pro M . Initial Experience With the New Ahmed Glaucoma Valve Model M4: Short-term Results. J Glaucoma. 2015; 25(5):e475-80. DOI: 10.1097/IJG.0000000000000324. View

3.
Ayyala R, Flores A, Haller E, Margo C . Comparison of different biomaterials for glaucoma drainage devices: part 2. Arch Ophthalmol. 2000; 118(8):1081-4. DOI: 10.1001/archopht.118.8.1081. View

4.
Hu W, Pro M, Fudemberg S, Moster M . Explantation of the novel Ahmed glaucoma valve M4 implant. J Glaucoma. 2014; 24(2):e1-4. DOI: 10.1097/IJG.0000000000000192. View

5.
Gil-Carrasco F, Jimenez-Roman J, Turati-Acosta M, Bello-Lopez Portillo H, Isida-Llerandi C . Comparative study of the safety and efficacy of the Ahmed glaucoma valve model M4 (high density porous polyethylene) and the model S2 (polypropylene) in patients with neovascular glaucoma. Arch Soc Esp Oftalmol. 2016; 91(9):409-14. DOI: 10.1016/j.oftal.2016.02.009. View